Abstract:Adult skeletal muscle can regenerate effectively after mild physical or chemical insult. Muscle trauma or disease can overwhelm this innate capacity for regeneration and result in heightened inflammation and fibrotic tissue deposition resulting in loss of structure and function. Recent studies have focused on biomaterial and stem cell-based therapies to promote skeletal muscle regeneration following injury and disease. Many stem cell populations besides satellite cells are implicated in muscle regeneration. These stem cells include but are not limited to mesenchymal stem cells, adipose-derived stem cells, hematopoietic stem cells, pericytes, fibroadipogenic progenitors, side population cells, and CD133<sup>+</sup> stem cells. However, several challenges associated with their isolation, availability, delivery, survival, engraftment, and differentiation have been reported in recent studies. While acellular scaffolds offer a relatively safe and potentially off-the-shelf solution to cell-based therapies, they are often unable to stimulate host cell migration and activity to a level that would result in clinically meaningful regeneration of traumatized muscle. Combining stem cells and biomaterials may offer a viable therapeutic strategy that may overcome the limitations associated with these therapies when they are used in isolation. In this article, we review the stem cell populations that can stimulate muscle regeneration in vitro and in vivo. We also discuss the regenerative potential of combination therapies that utilize both stem cell and biomaterials for the treatment of skeletal muscle injury and disease. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1246-1262, 2019.

Cellular dynamics of myogenic cell migration: molecular mechanisms and implications for skeletal muscle cell therapies

Reprogramming Autologous Skeletal Myoblasts to Express Cardiomyogenic Function. Challenges and Possible Approaches.

New Perspectives in the Treatment of Damaged Myocardium Using Autologous Skeletal Myoblasts

Myoblast Therapy: from Bench to Bedside

Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration

Biomaterial-based delivery for skeletal muscle repair

In vitro culture and migration assay of mouse smooth muscle progenitor cells

Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy

Biomaterial and stem cell‐based strategies for skeletal muscle regeneration

Myoblast Migration and Directional Persistence Affected by Syndecan-4-Mediated Tiam-1 Expression and Distribution

Cell migration: implications for repair and regeneration in joint disease

The Critical Role of Cell Homing in Cytotherapeutics and Regenerative Medicine

Factors Influencing Myogenic Differentiation of Adipose-Derived Stem Cells and Their Application in Muscle Regeneration

Matrix scaffolding for stem cell guidance toward skeletal muscle tissue engineering

The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration

Importance and regulation of adult stem cell migration

Coaxing stem cells for skeletal muscle repair

Cells, scaffolds, and bioactive factors: Engineering strategies for improving regeneration following volumetric muscle loss

Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy

Cellular interactions and microenvironment dynamics in skeletal muscle regeneration and disease

Three-dimensional imaging studies in mice identify cellular dynamics of skeletal muscle regeneration